Submitted by Anonymous (not verified) on 20 August 2026 - 10:34
Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 9, Status: Authorised
Source: